Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic

Lijuan Guo1, Yuanhua Yang1, Jie Liu2

  • 1Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, P.R. China; Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing, P.R. China.

Plos One
|July 1, 2014
PubMed

Insights

A distinct microRNA signature in the blood of patients with chronic thromboembolic pulmonary hypertension (CTEPH) could serve as a diagnostic biomarker. Reduced levels of let-7b may contribute to CTEPH development by impacting cell function.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive vascular disease.
  • MicroRNAs (miRNAs) are key regulators of cellular processes and potential disease biomarkers.
  • Circulating miRNA profiles may reflect disease state and offer insights into CTEPH pathogenesis.

Purpose of the Study:

  • To identify differentially expressed miRNAs in CTEPH patients compared to healthy controls.
  • To investigate the functional roles of these miRNAs and their targets in CTEPH.
  • To explore the diagnostic potential of miRNA signatures in CTEPH.

Main Methods:

  • Microarray analysis for miRNA profiling.
  • Quantitative reverse transcription PCR (qRT-PCR) for validation.
  • In silico target prediction, Gene Ontology, and KEGG pathway analysis for functional enrichment.
  • Fluorescence reporter assays, ELISA, western blotting, and wound healing assays for target validation and functional assessment.

Main Results:

  • Thirty-five miRNAs were differentially expressed in CTEPH patients, with a 17-miRNA signature demonstrating high diagnostic accuracy (>0.9 sensitivity and specificity).
  • Let-7b, an anti-oncogenic miRNA, was significantly downregulated (approx. 0.25 fold) in CTEPH patients.
  • Endothelin-1 (ET-1) and Transforming Growth Factor Beta Receptor 1 (TGFBR1) were identified as direct targets of let-7b, and altered let-7b levels affected ET-1/TGFBR1 expression and cell migration in pulmonary arterial cells.

Conclusions:

  • CTEPH patients exhibit an aberrant circulating miRNA profile that may aid in biomarker screening and understanding disease pathogenesis.
  • Reduced let-7b levels are implicated in CTEPH pathogenesis, potentially through modulation of ET-1 expression and pulmonary arterial cell function.